ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2181

Gut Microbe-derived Short-Chain Fatty Acids Regulate Arthritis and Myositis During Chikungunya Virus Infection

Fang R. Zhao1, Emma Winkler1, Chun-Jun Guo2, Russell B. Williams3, Leran Wang1, Ana Jung1, Lindsay Droit1, Leah Heath1, Ting-ting Li2, Matthias Mack4, Megan T. Baldridge1, Thaddeus S. Stappenbeck5, Larissa B. Thackray1, Scott A. Handley1, Michael A. Fischbach6 and Michael S. Diamond1, 1Washington University in St. Louis, St. Louis, MO, 2Cornell University, New York, NY, 3Donald Danforth Plant Science Center, St. Louis, MO, 4University Hospital Regensburg, Regensburg, Germany, 5Cleveland Clinic, Cleveland, OH, 6Stanford University, Stanford, CA

Meeting: ACR Convergence 2022

Keywords: Arthritis, Infectious, immunology, microbiome, Monocytes/macrophages, T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Abstracts: RA – Animal Models

Session Type: Abstract Session

Session Time: 3:00PM-4:00PM

Background/Purpose: The intestinal microbiota regulates musculoskeletal inflammation and antibiotic use increases risk for the development or relapse of inflammatory arthritis. However, the basis for this is not well understood. Even less is known about the effects of the commensal intestinal microbiota on tissue inflammation in the context of viral arthritis such as that resulting from chikungunya virus (CHIKV). We aimed to define the cellular and immunological mechanisms by which the commensal gut microbiome regulates inflammation in a mouse model of CHIKV arthritis.

Methods: Subcutaneous footpad injection of CHIKV in mice recapitulates many features of human disease, including joint swelling, tenosynovitis, and myositis. To perturb the gut microbiome, mice were treated with a 3-day course of the minimally absorbed oral antibiotics, vancomycin and ampicillin, which depletes many gut bacteria, primarily from the Bacteroidetes phylum, leading to relative overrepresentation of Proteobacteria and Firmicutes. Using a combination of germ-free mice, genetic mouse models, and genetically modified bacteria, we examined mechanisms by which gut microbes regulate viral arthritis.

Results: We show that perturbation of the intestinal microbiome with oral antibiotics results in increased infiltration of inflammatory cells and exacerbation of musculoskeletal inflammation in our mouse model of CHIKV arthritis. Antibiotic-induced gut dysbiosis leads to increased paracellular intestinal permeability. Joint swelling depends partially on MyD88 expression in the intestinal epithelium, with contributions from Toll-like receptor 4, monocytes, and inflammatory effector CD4+ T cells. Germ-free mice do not exhibit enhanced alphavirus-induced inflammatory arthritis seen after microbiota depletion. The effects of gut dysbiosis occur independently of viral burden, and are mediated by depletion of gut microbe-derived short chain fatty acids (SCFA). Indeed, treatment with exogenous SCFA (butyrate and propionate, but not acetate), or gut microbial transplant with bacterial species that generate SCFA, leads to reversal of intestinal permeability and ameliorates arthritis and myositis during CHIKV infection.

Conclusion: While microbial dysbiosis in the gastrointestinal tract has previously been linked to arthritis, the underlying mechanisms had been less well understood. Our work provides key mechanistic insight into how intestinal microbes and their metabolites regulate the pathogenesis of viral arthritis through an interplay between intestinal epithelial cells, pattern recognition receptors, and immune cells. Relevant pathways elucidated by our work may serve as potential therapeutic targets for modulating musculoskeletal inflammation in the context of autoimmunity and arthritogenic virus infection.


Disclosures: F. Zhao, None; E. Winkler, None; C. Guo, None; R. Williams, None; L. Wang, None; A. Jung, None; L. Droit, None; L. Heath, None; T. Li, None; M. Mack, None; M. Baldridge, None; T. Stappenbeck, None; L. Thackray, None; S. Handley, None; M. Fischbach, None; M. Diamond, None.

To cite this abstract in AMA style:

Zhao F, Winkler E, Guo C, Williams R, Wang L, Jung A, Droit L, Heath L, Li T, Mack M, Baldridge M, Stappenbeck T, Thackray L, Handley S, Fischbach M, Diamond M. Gut Microbe-derived Short-Chain Fatty Acids Regulate Arthritis and Myositis During Chikungunya Virus Infection [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/gut-microbe-derived-short-chain-fatty-acids-regulate-arthritis-and-myositis-during-chikungunya-virus-infection/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gut-microbe-derived-short-chain-fatty-acids-regulate-arthritis-and-myositis-during-chikungunya-virus-infection/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology